Dr Reddys Laboratories Ltd

DRREDDY21 Jun 2024
Pharmaceuticals
+45.45 (+0.76%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Dr Reddy's Labs
Dr Reddys Laboratories Ltd
Pharmaceuticals
DRREDDY21 Jun 2024
+45.45 (+0.76%)
1D
1M
6M
1Y
5Y
All

Dr Reddy's Labs - Share Price & Details

Lowest Today
5961
Highest Today
6053.95
Today’s Open
5974
Prev. Close
5963.25
52 Week High
6505.5
52 Week Low
4891.55
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
22.41%
Upper Circuit
Lower Circuit
P/E TTM
23.09
P/B Ratio
4.14
Traded Value(Cr)
0.00
EPS TTM
260.27
Book value
Dividend
0.67%

Price Performance

-1.24 %
1 Wk
3.94 %
1 M
-1.97 %
3 M
22.41 %
1 Y
3.26 %
YTD

Traded Volume Movement

Technical Details

Support 3
5860
Support 2
5908
Support 1
5960
Pivot Point :
6008
Resistance 1
6060
Resistance 2
6108
Resistance 3
6160

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Dr Reddys Laboratories Ltd
₹6,008.70(+45.45/0.76%)
6,008.70+45.45100,239.7622.4123.094.14
Astrazeneca Pharma India Ltd
₹6,350.95(-24.05/-0.38%)
6,350.95-24.0515,877.3872.61106.2022.30
Cipla Ltd
₹1,540.95(-3.50/-0.23%)
1,540.95-3.50124,423.3552.7733.504.45
Bliss GVS Pharma Ltd
₹103.90(+0.90/0.87%)
103.90+0.901,088.2225.8214.351.10
Amrutanjan Health Care Ltd
₹751.50(-7.00/-0.92%)
751.50-7.002,172.6321.5748.307.53
Abbott India Ltd
₹26,843.60(-60.65/-0.23%)
26,843.60-60.6557,042.6518.3347.4915.42

About Dr Reddys Laboratories Ltd

Dr Reddys Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 100239.76 crores. It has reported a sales of Rs. 5081.8 crores and a net profit of Rs. 1034.8 crores for the quarter ended December 2018. The company management includes K Satish Reddy, G V Prasad,K Satish Reddy,Kalpana Morparia,Shikha Sanjaya Sharma,Leo Puri,K P Krishnan,Pennv Wan,K Randhir Singh,Arun M. Kumar,Claudio Albrecht (Dr Reddys Laboratories Ltd) among others.
Chairman
K Satish Reddy
Registered office
8-2-337 Road No 3,Banjara Hills,Hyderabad,Telangana,500034
FAX :91-40-49002999
Background
Incorporation Year1984
Face Value₹5
Market Lot1

Latest News

Broader indices hit fresh highs; 70 small-caps rise between 10-40%
The Indian stock market saw mixed performance, with BSE Sensex adding 217.13 points or 0.28% to end at 77,209.90, and Nifty50 index rising 35.5 points or 0.15% to close at 23,501.10. Foreign institutional investors (FIIs) bought equities worth Rs 2,030.83 crore, and Domestic Institutional Investors (DII) bought equities worth Rs 6293.38 crore, driving market sentiment.
22 Jun 2024 | 10:23 AM
Broader indices hit fresh highs; 70 small-caps rise between 10-40%
The Indian stock market saw mixed performance, with BSE Sensex adding 217.13 points or 0.28% to end at 77,209.90, and Nifty50 index rising 35.5 points or 0.15% to close at 23,501.10. Foreign institutional investors (FIIs) bought equities worth Rs 2,030.83 crore, and Domestic Institutional Investors (DII) bought equities worth Rs 6293.38 crore, driving market sentiment.
22 Jun 2024 | 10:23 AM
Kripashankar Maurya of Choice Broking recommends these 4 fundamental picks
Here is the summarized text: The Indian stock market has performed decently in 2024, with the Nifty 50 up 8% year-to-date. Experts recommend betting on quality stocks with strong fundamentals for the medium to long term. Four stocks - 📌Greenply Industries, 📌Fiem Industries, 📌Allied Digital Services, and 📌DCX Systems - are expected to deliver healthy double-digit gains in the next six months.
22 Jun 2024 | 02:45 PM
10 BSE 100 stocks turned multibaggers in one year but Zomato
Trent, Zomato, and Bajaj Auto have delivered multibagger returns of 213%, 162%, and 107% respectively over the past year, with a beta lower than one, indicating lower volatility. Five PSU stocks, including Power Finance Corporation, GAIL, and Bharat Electronics, have also yielded over 100% returns but with high volatility.
22 Jun 2024 | 02:40 PM
Block deals worth over Rs 40,543 crore this week
Over 36 companies from large, mid, and smallcap segments witnessed block deals worth Rs 40,543 crore, with Axis Bank leading the largecap segment with a deal worth Rs 2,089 crore. The midcap segment saw deals worth Rs 28,240 crore, led by Indus Towers' deal worth Rs 17,198 crore. Smallcap stocks saw deals worth Rs 5,737 crore, led by Aster DM Healthcare's deal worth Rs 1,576 crore.
22 Jun 2024 | 02:10 PM

How to buy Dr Reddy's Labs shares on nse?

To buy Dr Reddy's Labs shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Dr Reddy's Labs share price today?

The Dr Reddy's Labs shares price on nse is Rs.6008.7 today.

What is the market cap of Dr Reddy's Labs shares on BSE ?

The company has a market capitalization of Rs.100239.76Cr

What is the PE & PB ratio of Dr Reddy's Labs shares ?

PE is 23.09 and PB is 4.14

What is the 52 Week High and Low of Dr Reddy's Labs shares?

Dr Reddy's Labs stock price high: Rs.6505.5 Dr Reddy's Labs stock price low: Rs.4891.55

Is Dr Reddy's Labs an effective investment?

As on 7th April, Dr Reddy’s Lab stock price has risen by 31.15% over the past 3 years. 

Investing in stocks, like any other capital investment, involves a certain amount of risk. To mitigate the risks, it's important to research, get professionals' help, and keep up-to-date with market trends.

What is the EPS of Dr Reddy's Labs shares?

For the quarter of Dec 2022, the EPS of Dr Reddy’s Labs was Rs. 74.7/ Share.

Who are the major stockholders of Dr Reddy's Labs shares?

The major stockholders of Dr Reddy’s Labs are: 

What is the ROI of Dr Reddy's Labs shares?

As on 7th April, Dr Reddy’s Labs has given an ROI of 8.53% over the past 12 months.

What are the primary indicators used to evaluate Dr Reddy's Labs?

There are several key parameters that investors may consider when evaluating whether to invest in Dr Reddy's Laboratories Ltd. :

  • Financial performance
  • Market position
  • Management quality
  • Valuation 
  • Regulatory compliance

How has the profitability of Dr Reddy's Labs Limited evolved over time?

Dr Reddy’s total standalone revenues have steadily grown over the past five years from Rs. 9563.3 crores in March 2018 to Rs. 14887.2 crores in March 2022. And the net profit increased from Rs. 566.9 crores to Rs. 1623.2 crores for the same period. 

Click here to see your activities